Țară: Singapore
Limbă: engleză
Sursă: HSA (Health Sciences Authority)
ACYCLOVIR
JOYSON PTE. LTD.
J05AB01
200 mg
TABLET
ACYCLOVIR 200 mg
ORAL
Prescription Only
SIAM BHEASACH CO LTD
ACTIVE
1997-07-16
VILERM ® (200 MG TABLET) Each tablet contains Acyclovir 200 mg VILERM ® (400 MG TABLET) Each tablet contains Acyclovir 400 mg VILERM ® (800 MG TABLET) Each tablet contains Acyclovir 800 mg (INN name : Aciclovir) PRODUCT DESCRIPTION:- VILERM ® (200 MG TABLET) Light blue, hexagonal and flat tablet with logo “ ” one side and “VILERM 200” on the other VILERM ® (400 MG TABLET) Yellow, hexagonal and flat tablet with logo “ ” one side and “VILERM 400” on the other VILERM ® (800 MG TABLET) Light blue, oblong and biconvex tablet with “VILERM” one side and “800” on the other PROPERTIES :- PHARMACODYNAMICS :- Mechanism of Action Acyclovir is a synthetic purine nucleoside analogue with inhibitory activity against human herpes viruses, including Herpes simplex virus (HSV) types 1 and 2, Varicella zoster virus (VZV), Epstein Barr virus (EBV) and Cytomegalovirus (CMV). The enzyme thymidine kinase (TK) of normal, non-infected cells does not use acyclovir effectively as a substrate, hence toxicity to mammalian host cells is low; however, TK encoded by HSV, VZV and EBV converts acyclovir to acyclovir monophosphate, a nucleoside analogue, which is further converted to the diphosphate and finally to the triphosphate by cellular enzymes. Acyclovir triphosphate interferes with the viral DNA polymerase and inhibits viral DNA replication with the resultant chain termination following its incorporation into the viral DNA. Pharmacodynamic Effects Prolonged or repeated course of acyclovir in severely immunocompromised individuals may results in the selection of virus strains with reduced sensitivity, which may not respond to be continued acyclovir treatment. All patients should be cautioned to ensure they avoid the potential of virus transmission, particularly when active lesions are present. PHARMACOKINETICS :- Acyclovir is only partially absorbed from the gut. Mean steady state peak plasma concentrations (C ss max) following doses of 200 mg administered four-hourly were 3.1 μ Mol (0.7 μ g/mL) and equivalen Citiți documentul complet